Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2017 1
2019 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
Matsumoto H, Igarashi C, Tachibana T, Hihara F, Shinada M, Waki A, Yoshida S, Naito K, Kurihara H, Ueno M, Ito K, Higashi T, Yoshii Y. Matsumoto H, et al. Among authors: naito k. Pharmaceutics. 2022 Sep 12;14(9):1928. doi: 10.3390/pharmaceutics14091928. Pharmaceutics. 2022. PMID: 36145676 Free PMC article.
Characterization and Stabilization of a New 64Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography.
Matsumoto H, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang MR, Yoshida S, Naito K, Kurihara H, Ueno M, Ito K, Higashi T, Yoshii Y. Matsumoto H, et al. Among authors: naito k. Pharmaceutics. 2021 Dec 28;14(1):67. doi: 10.3390/pharmaceutics14010067. Pharmaceutics. 2021. PMID: 35056963 Free PMC article.
Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates.
Matsumoto H, Watabe T, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang MR, Tashima H, Yamaya T, Ooe K, Shimosegawa E, Hatazawa J, Yoshida S, Naito K, Kurihara H, Ueno M, Ito K, Higashi T, Yoshii Y. Matsumoto H, et al. Among authors: naito k. Pharmaceuticals (Basel). 2021 Sep 23;14(10):950. doi: 10.3390/ph14100950. Pharmaceuticals (Basel). 2021. PMID: 34681174 Free PMC article.
Increased phosphorylation of Akt in triple-negative breast cancers.
Umemura S, Yoshida S, Ohta Y, Naito K, Osamura RY, Tokuda Y. Umemura S, et al. Among authors: naito k. Cancer Sci. 2007 Dec;98(12):1889-92. doi: 10.1111/j.1349-7006.2007.00622.x. Epub 2007 Sep 24. Cancer Sci. 2007. PMID: 17892507 Free article.